Clinical Trial Update: Dapagliflozin Effect on Erythropoiesis and Physical Fitness [Phase 4]

View source ↗

Summary

Phase 4 trial update on dapagliflozin focusing on erythropoiesis and physical fitness has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Dapagliflozin (dapagliflozin)

Snippet

Sponsor: University Hospital Tuebingen | Conditions: Type 2 Diabetes Mellitus (T2DM) | Phase 4 | Status: WITHDRAWN